BioMarin Pharmaceutical, Inc. (BMRN)
64.53
-0.76
(-1.16%)
USD |
NASDAQ |
Aug 28, 15:37
BioMarin Pharmaceutical Total Return Price : 64.53 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 65.29 |
| August 26, 2026 | 65.61 |
| August 25, 2026 | 66.12 |
| August 24, 2026 | 65.07 |
| August 21, 2026 | 66.70 |
| August 20, 2026 | 67.68 |
| August 19, 2026 | 69.33 |
| August 18, 2026 | 66.99 |
| August 17, 2026 | 66.64 |
| August 14, 2026 | 67.36 |
| August 13, 2026 | 68.53 |
| August 12, 2026 | 70.24 |
| August 11, 2026 | 69.55 |
| August 10, 2026 | 68.88 |
| August 07, 2026 | 63.81 |
| August 06, 2026 | 61.46 |
| August 05, 2026 | 59.91 |
| August 04, 2026 | 60.72 |
| August 03, 2026 | 60.00 |
| July 31, 2026 | 60.02 |
| July 30, 2026 | 60.58 |
| July 29, 2026 | 61.37 |
| July 28, 2026 | 62.07 |
| July 27, 2026 | 60.27 |
| July 24, 2026 | 59.33 |
| Date | Value |
|---|---|
| July 23, 2026 | 58.87 |
| July 22, 2026 | 58.40 |
| July 21, 2026 | 59.21 |
| July 20, 2026 | 59.11 |
| July 17, 2026 | 59.59 |
| July 16, 2026 | 60.00 |
| July 15, 2026 | 58.95 |
| July 14, 2026 | 58.64 |
| July 13, 2026 | 59.20 |
| July 10, 2026 | 59.12 |
| July 09, 2026 | 59.97 |
| July 08, 2026 | 59.75 |
| July 07, 2026 | 60.35 |
| July 06, 2026 | 58.79 |
| July 02, 2026 | 58.99 |
| July 01, 2026 | 57.82 |
| June 30, 2026 | 57.22 |
| June 29, 2026 | 57.67 |
| June 26, 2026 | 59.00 |
| June 25, 2026 | 57.35 |
| June 24, 2026 | 57.33 |
| June 23, 2026 | 56.50 |
| June 22, 2026 | 55.90 |
| June 18, 2026 | 54.69 |
| June 17, 2026 | 55.02 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Incyte Corp. | 123.70 |
| Alnylam Pharmaceuticals, Inc. | 236.36 |
| Vertex Pharmaceuticals, Inc. | 542.30 |
| Ionis Pharmaceuticals, Inc. | 60.89 |
| Regeneron Pharmaceuticals, Inc. | 793.93 |